NEW YORK: Two years since Covid-19 first emerged, global central banks are about to determine if their economies are strong enough to withstand the impact of its most elaborate mutation yet.
Officials at over a dozen monetary authorities, including the US Federal Reserve (Fed), will once again try to make a policy judgment about a medical phenomenon, being forced to take a view before scientists fully understand the implications of the Omicron variant.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
